Immunome Competitors and Similar CompaniesClear all
Immunome's competitors and similar companies include Galectin Therapeutics and Amolyt Pharma.
 Immunome Immunome is a biotech company focused on cancer immunotherapies fueled by the human immune system. |  Galectin Therapeutics Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer. |  Amolyt Pharma Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer. | |
Founding Date | Founding Date 2008 | Founding Date 2001 | Founding Date 2015 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Exton, US HQ | Locations Norcross, US HQ | Locations Écully, FR HQ Cambridge, US |
Employees | Employees 264% decrease | Employees 717% increase | Employees 373% decrease |
Valuation ($) | Valuation ($) 746.5 m | Valuation ($) 155.1 m | Valuation ($) N/A |
Financial | |||
Net income | Net income ($212.4m) (FY, 2025) | Net income ($30.8m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 23.8m | Total funding raised N/A | Total funding raised $ 93.1m |
For sources of this data, please see the company profile
View Company Profiles
Galectin Therapeutics
HQ
Norcross, US
Employees
7↑ 17% increase
Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer.
View companyAmolyt Pharma
HQ
Écully, FR
Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer.
View company